Sobi Returns To Deal-Making With ADC Lymphoma Licensing Pact

Pays $55m Upfront For Rights To Zynlonta

 
• By Kevin Grogan
Guido Oelkers
Sobi CEO Guido Oelkers • Source: Archive

More from Rare Diseases

More from Scrip